Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.8K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

472
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
472
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

562
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
562
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

88
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
88
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

105
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
105
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

707
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
707

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Survival and Success of Teeth With External Cervical Resorption: A Multi-Centre, Retrospective Study.

International endodontic journal·2026
Same author

Description of an independently developed quality assessment tool to meet emergency department credentialing and Emergency Ultrasound Fellowship Accreditation Council guidelines.

The ultrasound journal·2026
Same author

56-Year-Old Man With Dyspnea and Volume Overload.

Journal of the American College of Emergency Physicians open·2026
Same author

Transthoracic echocardiography is superior to AHA guidelines location in identifying the left ventricle for chest compressions.

Resuscitation plus·2026
Same author

Mentorship Strategies and Illustrative Cases at Every Career Stage.

AEM education and training·2026
Same author

Retreatment of Bioceramic Sealers Using a Novel Solvent: Dissolution, Patency, and Dentinal Effects.

Journal of endodontics·2026
Same journal

Assessing the sustainability of reef and demersal fish stocks in Northwest México under a data-limited approach.

PeerJ·2026
Same journal

The impact of virtual reality exercise programs on postpartum pelvic pain and disability among women with lumbopelvic pain.

PeerJ·2026
Same journal

Soil salinity modulates fatty acid composition and antioxidant capacity of rice bran oil.

PeerJ·2026
Same journal

The optimal dose of brisk walking for improving blood pressure in hypertensive patients: a systematic review and bayesian meta-analysis of randomized controlled trials.

PeerJ·2026
Same journal

Enhanced sweet pepper yield through high-intensity artificial lighting and optimized plant density in high-latitude winter production.

PeerJ·2026
Same journal

Prenatal corticosteroid use improves the severity and complications of necrotizing enterocolitis in preterm infants: a retrospective multicenter clinical study in China.

PeerJ·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

3.1K

Are improper kinetic models hampering drug development?

Ryan Walsh1

  • 1Department of Chemistry, Carleton University , Ottawa, ON , Canada.

Peerj
|November 7, 2014
PubMed
Summary
This summary is machine-generated.

Enzyme kinetic inhibition models are often overly complex, hindering reproducibility. This study introduces a simpler, empirical approach to inhibition modeling, improving drug interaction analysis and disease mechanism research.

Keywords:
Alzheimer’s diseaseAmyloidDiseaseDrug developmentEmpirical modelsEnzyme inhibitionEnzyme kineticsGamma-secretaseIrreproducibilityReproducibility

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.2K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K

Related Experiment Videos

Last Updated: Apr 21, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

3.1K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.2K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Enzyme kinetics

Background:

  • Reproducibility in biological data is a significant challenge in scientific research.
  • Overly complex enzyme kinetic inhibition models contribute to this issue by conflating inhibitor binding and effect.
  • Current models are numerous, complex, and rarely compared, leading to the adoption of simpler, less informative methods like IC50s.

Purpose of the Study:

  • To address the problem of reproducibility in biological data by simplifying enzyme kinetic inhibition models.
  • To propose an empirical approach to inhibition modeling that distinguishes between inhibitor binding and inhibitory effect.
  • To develop broadly applicable models for easier comparison and rational analysis of drug interactions.

Main Methods:

  • Empirical analysis of inhibitory data to develop logical inhibition models.
  • Distinguishing clearly between inhibitor binding and inhibitory effect.
  • Utilizing Excel for kinetic modeling, demonstrated with DAPT (a γ-secretase modulator).

Main Results:

  • Development of simple, logical enzyme inhibition models through empirical analysis.
  • Demonstration of the broad applicability of the empirical approach.
  • Successful kinetic modeling of DAPT's dual activity (activation and inhibition) of γ-secretase.

Conclusions:

  • The proposed empirical kinetic method offers an improved approach to modeling enzyme inhibition.
  • This method enhances the investigation of disease mechanisms and therapeutic interventions.
  • Simplified and standardized inhibition models improve the reproducibility and comparability of research findings.